Clinical Trials Directory

Trials / Unknown

UnknownNCT02427971

A Comparison Between the Aysis® Cs2 (General Electrics) Ventilator in EtControl® Mode and the Perseus® A 500 (Dräger) in VaporView® Mode on Maniability and Consumption of Desflurane

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Saint Antoine University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The Aysis® Cs2 ventilator offers an automated control of end-tidal inhalation anesthetic concentration, the EtControl® mode. A low Fresh Gas Flow (FGF) (0.5L/min) is kept during the maintenance of the anesthesia, decreasing the expensive consumption of halogenated agents. The Perseus® A 500 offers a VaporView® mode that gives the evolution of inspired (Fi) and end-tidal (Fe) fractions of halogenated agents for 20 minutes based on the delivered fraction (Fd). FGF remains adjusted manually by the practitioner. This mode also makes it possible to maintain a low FGF (0.5 L/min), provided the halogen Fd is set to maintain a steady Fe curve. The goal of this work was to compare the maniability of the intraoperative administered concentrations and the consumption of Desflurane between these 2 modalities of administration.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2015-04-28
Last updated
2015-04-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02427971. Inclusion in this directory is not an endorsement.